Clinical trial
Adalimumab in Severe and Acute Sciatica
NCT00470509 · University Hospital, Geneva, Other · Completed
Key facts
| NCT number | NCT00470509 |
|---|---|
| Title | Adalimumab in Severe and Acute Sciatica |
| Official title | Adalimumab in Severe and Acute Sciatica |
| Acronym | ASAS |
| Lead sponsor | University Hospital, Geneva, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sciatica |
| Intervention type | Drug |
| Interventions | Adalimumab, Placebos |
| Enrollment | 61 |
| Start date | May 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | May 7, 2007 |
| Last update posted | Apr 22, 2019 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: